DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Morris VK, Salem ME, Nimeiri H. et al.
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
Lancet Oncol 2017;
18 (04) 446-453
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.